Verrica Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.79%37.190.9%$1871.92m
ABBVAbbVie, Inc. 0.53%104.761.9%$1089.10m
JNJJohnson & Johnson 0.17%143.920.7%$1079.06m
BMYBristol-Myers Squibb Co. 0.41%63.101.0%$715.22m
MRKMerck & Co., Inc. -0.18%79.920.7%$692.93m
LLYEli Lilly & Co. 1.49%146.911.1%$689.35m
AZNAstraZeneca Plc -0.04%52.581.2%$288.20m
GSKGlaxoSmithKline Plc -0.47%37.060.2%$233.52m
NVSNovartis AG 0.40%89.540.2%$180.16m
NVONovo Nordisk A/S 2.12%67.540.1%$96.47m
RGENRepligen Corp. 2.24%185.497.1%$94.79m
SNYSanofi 1.55%50.980.2%$76.43m
ARCTArcturus Therapeutics Holdings, Inc. 24.29%75.360.0%$71.65m
RPRXRoyalty Pharma Plc 2.16%41.860.2%$67.76m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 1.39%90.870.0%$67.48m

Company Profile

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.